Skip to content
Trial Eligibility
Menu

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

NCT07365995

This study is recruiting at 17 US sites in 10 states, according to its ClinicalTrials.gov record last updated .

Summary

This study will test whether BNT324 is safe and works better against metastatic castration-resistant prostate cancer (mCRPC) than the current standard of care (SoC) chemotherapy, which is docetaxel (given together with the steroid medicines prednisone or prednisolone). The study will include participants with mCRPC that have been previously treated with androgen receptor pathway inhibitor, but with no previous taxane-based systematic chemotherapy for mCRPC.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Metastatic Castration-resistant Prostate Cancer

Eligibility basics and study details

Study type
Interventional
Phase
Phase 3
Ages
18 years and older
Sex
Male
Healthy volunteers
Not accepted
Sponsor
BioNTech SE
Last updated on ClinicalTrials.gov
September 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

California · 1

  • Sansum Clinic · Santa Barbara, CA

Colorado · 1

  • Rocky Mountain Cancer Centers · Aurora, CO

Florida · 3

  • Florida Cancer Specialists- Fort Myers · Fort Myers, FL
  • Florida Cancer Specialists- St. Petersburg · St. Petersburg, FL
  • Florida Cancer Specialists- West Palm Beach · West Palm Beach, FL

Illinois · 2

  • Illinois Cancer Specialists · Niles, IL
  • Illinois CancerCare PC · Peoria, IL

Maryland · 1

  • Maryland Oncology Hematology · Rockville, MD

New York · 1

  • White Plains Hospital · White Plains, NY

Ohio · 1

  • Oncology/Hematology Care, Inc. · Cincinnati, OH

Tennessee · 1

  • SCRI Oncology Partners · Nashville, TN

Texas · 4

  • Texas Oncology South Austin · Austin, TX
  • Texas Oncology Gulf Coast · Houston, TX
  • Texas Oncology, P.A. - Tyler · Tyler, TX
  • Texas Oncology - West Texas · Wichita Falls, TX

Virginia · 2

  • Virginia Cancer Specialists PC · Fairfax, VA
  • Virginia Oncology Associates · Norfolk, VA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.